• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background
    English
    Chinese
    French
    Japanese
    Korean
    German
    Spanish

    Tissue Microarray Market Size

    ID: MRFR/LS/0706-CR
    186 Pages
    Rahul Gotadki
    July 2019

    Tissue Microarray Market Research Report Information by Procedure (Immunohistochemistry, Fluorescent In-Situ Hybridization and Frozen Tissue Array), Technology (DNA Microarray, Polymerase Chain Reaction (PCR), Next-Generation Sequencing, Northern Blotting and Western Blotting), Application (Oncology, Gene Expression Profiling, SNP Detection, Double-Stranded B-DNA Microarrays, Comparative Genomi...

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Tissue Microarray Market Infographic

    Purchase Options

    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Summary Table of Contents Segmentation Download PDF

    Tissue Microarray Size

    Tissue Microarray Market Growth Projections and Opportunities

    The Tissue Microarray Market is firmly impacted by movements in biomedical exploration. As examination attempts extend, the interest for proficient devices for breaking down tissue tests develops, driving the reception of tissue microarrays in examinations connected with disease, genetic qualities, and other clinical fields. The rising universality of ongoing diseases, especially malignant growth, powers the interest for imaginative symptomatic and prognostic devices. Tissue microarrays act as important assets in concentrating on illness designs, adding to a more popularity in the Americas where the burden of constant diseases is significant. The drug business' emphasis on drug revelation and improvement impels the tissue microarray market. Tissue microarrays empower specialists to break down the declaration of specific proteins in different tissues, aiding in the distinguishing proof of potential medication targets and the assessment of medication adequacy. Developing interests in medical care foundation across the Americas add to the extension of the tissue microarray market. Medical services offices, research foundations, and analytic labs are embracing tissue microarrays to upgrade their capacities in tissue-based examinations and diagnostics. The maturing population in the Americas drives the interest for cutting edge symptomatic devices to address age-related diseases. Tissue microarrays, with their capacity to give detailed experiences into tissue creation, become instrumental in concentrating on age-related conditions, adding to market growth. The developing emphasis on customized medication in the Americas lines up with the abilities of tissue microarrays. These exhibits empower the examination of individual patient examples, aiding in the advancement of customized treatment systems and adding to the market's development.

    Tissue Microarray Market Size Graph
    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Get In Touch

    Leave a Comment

    FAQs

    What would be the tissue microarray market valuation by 2032?

    The valuation would be USD 26.47 Billion by 2032.

    What is the predicted CAGR for the tissue microarray market during the forecast period (2024-2032)?

    tissue microarray market CAGR would be 10.11% during the forecast period (2024-2032).

    What are the major tissue microarray market drivers?

    Increasing the use of drug discovery, the prevalence of cancer, better inclusion of biotechnology and pharmaceutical companies, and effective use of cost-effective and accurate diagnostic methods are the major drivers.

    What was the research organization segment valuation in 2023?

    The valuation was USD 1876.02 million.

    Which region would lead the tissue microarray market?

    The Americas would enjoy the dominance in the tissue microarray market.

    Market Summary

    The Global Tissue Microarray Market is projected to grow from 12.3 USD Billion in 2024 to 35.3 USD Billion by 2035, reflecting a robust growth trajectory.

    Key Market Trends & Highlights

    Tissue Microarray Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate (CAGR) of 10.07% from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 35.3 USD Billion, indicating substantial expansion.
    • In 2024, the market is valued at 12.3 USD Billion, laying a strong foundation for future growth.
    • Growing adoption of tissue microarray technology due to increasing demand for personalized medicine is a major market driver.

    Market Size & Forecast

    2024 Market Size 12.3 (USD Billion)
    2035 Market Size 35.3 (USD Billion)
    CAGR (2025-2035) 10.07%
    Largest Regional Market Share in 2024 latin_america)

    Major Players

    Agilent Technologies, Illumina, Inc., Protein Biotechnologies Inc., Asterand Bioscience, Pantomics Inc., Applied Microarrays, Arrayit, Phalanx Biotech, QIAGEN, Takara Bio, Perkin Elmer, Merck Sharp & Dohme Corp.

    Market Trends

    The ongoing advancements in tissue microarray technology are poised to enhance diagnostic accuracy and facilitate personalized medicine, thereby transforming the landscape of pathology and oncology.

    National Institutes of Health (NIH)

    Tissue Microarray Market Market Drivers

    Market Growth Projections

    The Global Tissue Microarray Market Industry is on a trajectory of substantial growth, with projections indicating an increase from 12.3 USD Billion in 2024 to 35.3 USD Billion by 2035. This growth reflects a compound annual growth rate (CAGR) of 10.07% from 2025 to 2035. Various factors contribute to this upward trend, including rising demand for personalized medicine, technological advancements, and increasing applications in drug development. The market's expansion is indicative of the growing recognition of tissue microarrays as essential tools in research and diagnostics, highlighting their potential to revolutionize the healthcare landscape.

    Rising Demand for Personalized Medicine

    The Global Tissue Microarray Market Industry experiences a notable surge in demand for personalized medicine, driven by advancements in genomics and molecular biology. As healthcare shifts towards tailored treatments, tissue microarrays facilitate the analysis of multiple tissue samples simultaneously, enhancing diagnostic accuracy. This trend is underscored by the projected market growth from 12.3 USD Billion in 2024 to 35.3 USD Billion by 2035, indicating a robust compound annual growth rate (CAGR) of 10.07% from 2025 to 2035. The ability to identify specific biomarkers through tissue microarrays plays a crucial role in developing targeted therapies, thereby propelling the industry forward.

    Supportive Government Initiatives and Funding

    Government initiatives and funding play a pivotal role in the growth of the Global Tissue Microarray Market Industry. Various health organizations and research institutions are increasingly investing in cancer research and personalized medicine, providing grants and funding opportunities for projects utilizing tissue microarrays. These initiatives not only enhance research capabilities but also promote collaboration between academia and industry, fostering innovation. The financial support from governments worldwide is likely to accelerate the adoption of tissue microarray technologies, contributing to the market's anticipated growth from 12.3 USD Billion in 2024 to 35.3 USD Billion by 2035, thereby reinforcing the industry's significance in advancing healthcare.

    Technological Advancements in Microarray Techniques

    Technological innovations significantly impact the Global Tissue Microarray Market Industry, as advancements in imaging and analysis techniques enhance the efficiency and accuracy of tissue microarray applications. Innovations such as automated slide scanning and high-throughput analysis allow researchers to process large volumes of samples with precision. These developments not only streamline workflows but also improve reproducibility in research findings. As a result, the industry is poised for growth, with the market expected to expand from 12.3 USD Billion in 2024 to 35.3 USD Billion by 2035. The integration of artificial intelligence in image analysis further indicates a transformative shift in how tissue microarrays are utilized in research and diagnostics.

    Increasing Prevalence of Cancer and Chronic Diseases

    The Global Tissue Microarray Market Industry is significantly influenced by the rising prevalence of cancer and chronic diseases worldwide. As the global burden of these diseases escalates, there is an increasing need for effective diagnostic tools that can facilitate early detection and treatment. Tissue microarrays enable researchers to analyze tumor heterogeneity and understand disease progression, which is vital for developing new therapeutic strategies. This growing demand for advanced diagnostic solutions is expected to contribute to the market's expansion, with projections indicating a growth from 12.3 USD Billion in 2024 to 35.3 USD Billion by 2035, reflecting a CAGR of 10.07% from 2025 to 2035.

    Growing Applications in Drug Development and Research

    The Global Tissue Microarray Market Industry is witnessing a surge in applications within drug development and research. Pharmaceutical companies increasingly utilize tissue microarrays to evaluate drug efficacy and safety profiles during preclinical studies. By analyzing the effects of new compounds on various tissue types, researchers can gain insights into potential therapeutic outcomes. This trend is expected to drive market growth, as the industry is projected to expand from 12.3 USD Billion in 2024 to 35.3 USD Billion by 2035. The ability to conduct high-throughput screening using tissue microarrays enhances the drug discovery process, making it a valuable tool for pharmaceutical research.

    Market Segment Insights

    Regional Insights

    Key Companies in the Tissue Microarray Market market include

    Industry Developments

      • In January 2017, Agilent technologies announced its collaboration with the Centre for Human Genetics of the University of Leuven and the University Hospital of Leuven in Belgium.
      • In July 2017, Horizon Discovery Group agreed to acquire GE Healthcare Dharmacon from parent General Electric for $85 million, creating a combined company focused on applying gene-editing and gene-modulation technologies in life science research.
      • In January 2017, Illumina Inc. announced the launch of a Single-Cell Sequencing Solution in collaboration with Bio-Rad. It is the first Next-Generation Sequencing (NGS) workflow for single-cell analysis providing researchers the ability to investigate the coordinated contribution of individual cells in tissue function, disease progression, and therapeutic response.

    Future Outlook

    Tissue Microarray Market Future Outlook

    The Global Tissue Microarray Market is projected to grow at a 10.07% CAGR from 2024 to 2035, driven by advancements in personalized medicine, increasing cancer research funding, and technological innovations in diagnostic tools.

    New opportunities lie in:

    • Develop novel tissue microarray platforms for high-throughput screening in drug discovery.
    • Leverage AI-driven analytics to enhance data interpretation and patient stratification.
    • Expand partnerships with biopharmaceutical companies for co-development of targeted therapies.

    By 2035, the market is expected to exhibit robust growth, positioning itself as a cornerstone in diagnostic and therapeutic advancements.

    Market Segmentation

    Report Overview

    Recent Developments
    • {"January 2017"=>[]}
    • {"July 2017"=>[]}
    • {"January 2017"=>[]}

    Market Segmentation

    By Region
    • {"Americas"=>[{"North America"=>["US", "Canada"]}]}
    • Latin America
    • {"Europe"=>[{"Western Europe"=>["Germany", "UK", "France", "Italy", "Spain", "Rest of Western Europe"]}]}
    • Eastern Europe
    • {"Asia-Pacific"=>["China", "Japan", "India", "Australia", "South Korea", "Rest of Asia-Pacific"]}
    • {"Middle East & Africa"=>["Middle East", "Africa"]}
    By End-user
    • Pharmaceutical and Biotechnological Companies
    • Research Organization
    By Procedure
    • Immunohistochemistry
    • Fluorescent in Situ Hybridization
    • Frozen Tissue Array
    By Technology
    • DNA Microarray
    • Polymerase Chain Reaction (PCR)
    • Next-Generation Sequencing
    • Northern Blotting
    • Western Blotting
    By Application
    • Oncology
    • Gene Expression Profiling
    • SNP Detection
    • Double-Stranded B-DNA Microarrays
    • Comparative Genomic Hybridization
    • Sequencing Bioinformatics

    Tissue Microarray Market Segmentation

    Major Key Players
    • Agilent Technologies
    • Illumina, Inc.
    • Asterand Bioscience
    •  Pantomics Inc.
    •  Applied Microarrays
    • Arrayit
    •  Phalanx Biotech
    • QIAGEN
    •  Takara Bio
    •  Perkin Elmer
    •  Merck Sharp & Dohme Corp.

    Report Scope

    Attribute/Metric Details
    Market Size 2023 11.18 (USD Billion)
    Market Size 2024 12.30 (USD Billion)
    Market Size 2032 26.47 (USD Billion)
    Compound Annual Growth Rate (CAGR) 10.11 % (2024 - 2032)
    Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    Base Year 2023
    Market Forecast Period 2024 - 2032
    Historical Data 2019 - 2023
      Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
      Key Vendors   Agilent Technologies, Illumina, Inc., Protein Biotechnologies Inc., Asterand Bioscience, Pantomics Inc., Applied Microarrays, Arrayit, Phalanx Biotech, QIAGEN, Takara Bio, Perkin Elmer, and Merck Sharp & Dohme Corp.
      Key Market Opportunities   New product launches and R&D Amongst major key Players
      Key Market Drivers ·  Increasing application in drug discovery ·  Increasing prevalence of cancer ·  Growing advancements in biotechnology and pharmaceutical companies ·  Rising demand for cost-effective and accurate diagnostic methods

    Market Highlights

    Author

    Rahul Gotadki
    Assistant Manager

    She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

    Leave a Comment

    Latest Comments

    John Doe
    john@example.com

    This is a great article! Really helped me understand the topic better.

    Posted on July 23, 2025, 10:15 AM
    Jane Smith
    jane@domain.com

    Thanks for sharing this. I’ve bookmarked it for later reference.

    Posted on July 22, 2025, 7:45 PM
    View All

    FAQs

    What would be the tissue microarray market valuation by 2032?

    The valuation would be USD 26.47 Billion by 2032.

    What is the predicted CAGR for the tissue microarray market during the forecast period (2024-2032)?

    tissue microarray market CAGR would be 10.11% during the forecast period (2024-2032).

    What are the major tissue microarray market drivers?

    Increasing the use of drug discovery, the prevalence of cancer, better inclusion of biotechnology and pharmaceutical companies, and effective use of cost-effective and accurate diagnostic methods are the major drivers.

    What was the research organization segment valuation in 2023?

    The valuation was USD 1876.02 million.

    Which region would lead the tissue microarray market?

    The Americas would enjoy the dominance in the tissue microarray market.

    1. Report Prologue
    2. Market Introduction
      1. Introduction
      2. 18
      3. 2.2
      4. Scope Of Study 18
      5. Research Objective 18
      6. Assumptions & Limitations 19
        1. Assumptions 19
        2. Limitations
      7. 19
      8. 2.5
      9. Market Structure 20
    3. Research Methodology
      1. Research Process 21
      2. Market Size Estimation 23
        1. Market Share Analysis 23
      3. Forecast Model
        1. Increasing Prevalence Of Cancer 26
        2. Increasing
        3. Increasing Demand For Cost-Effective
      4. 25
      5. 4
      6. Market Dynamics
      7. 4.1
      8. Drivers 26
      9. 4.1.1
      10. Increasing Application In Drug Discovery 26
      11. Advancements In Biotechnology And Pharmaceutical Companies 27
      12. And Accurate Diagnostic Methods 28
      13. Restraints 28
        1. Tissue Microarray Is That It May Not Be Fruitful
      14. For Heterogeneous Cancers 28
      15. Opportunities 28
      16. Mega Trends 29
        1. Increasing Use Of Sequence Bioinformatics 29
      17. Macroeconomic
      18. Indicators 29
      19. 4.6
      20. Technology Trends & Assessment 30
    4. Market Factor Analysis
      1. Porter’s Five Forces
        1. Bargaining Power Of Buyers 31
        2. Threat Of New Entrants
        3. Intensity Of Rivalry 32
      2. Model 31
      3. 5.1.1
      4. Bargaining Power Of Suppliers 31
      5. 32
      6. 5.1.4
      7. Threat Of Substitutes 32
      8. Value Chain Analysis 33
        1. R&D 33
        2. Clinical Test &
        3. Marketing & Sales 34
      9. Legal Issues 33
      10. 5.2.3
      11. Patenting & Manufacturing 34
      12. Pricing Analysis 34
      13. Investment Opportunity Analysis 35
      14. Merger &
      15. Acquisition Landscape 35
    5. Tissue Microarray Market, By Procedure
      1. Introduction 37
      2. Immunohistochemistry 38
      3. Fluorescent In Situ Hybridization
      4. 39
      5. 6.4
      6. Frozen Tissue Array 40
    6. Tissue Microarray Market, By Technology
      1. Introduction 41
      2. DNA Microarray 43
      3. Polymerase Chain Reaction (PCR) 44
      4. Next-Generation
      5. Sequencing 45
      6. 7.5
      7. Northern Blotting 46
      8. Western Blotting 47
    7. Tissue Microarray Market, By Application
      1. Introduction
      2. 48
      3. 8.2
      4. Oncology 49
      5. 8.3
      6. Gene Expression Profiling 50
      7. SNP Detection 51
      8. Double-Stranded B-DNA Microarrays 52
      9. Comparative
      10. Genomic Hybridization 53
      11. Sequencing Bioinformatics 54
    8. Tissue Microarray Market, By End User
      1. Introduction
      2. 55
      3. 9.2
      4. Pharmaceutical And Biotechnological Companies 56
      5. Research Organization 57
    9. Global Tissue Microarray Market,
      1. By Region
      2. 10.1
      3. Introduction 58
      4. 10.2
      5. Americas 60
      6. Tissue
    10. Microarray Market, By Procedure
    11. Tissue Microarray Market, By Technology
      1. Tissue Microarray Market,
      2. By Application
      3. Tissue
    12. Microarray Market, By End User
    13. U.S. 64
    14. Tissue Microarray Market, By Procedure
      1. Tissue Microarray
    15. Market, By Technology
    16. Tissue Microarray Market, By Application
    17. Tissue Microarray Market, By End User
      1. Tissue Microarray
    18. Canada 67
    19. Market, By Procedure
    20. Tissue Microarray Market, By Technology
    21. Tissue Microarray Market, By Application
      1. Tissue Microarray
    22. Market, By End User
    23. South America 70
    24. Tissue Microarray Market, By Procedure
      1. Tissue Microarray
    25. Market, By Technology
    26. Tissue Microarray Market, By Application
    27. Tissue Microarray Market, By End User
      1. Europe 74
      2. Tissue Microarray
    28. Market, By Procedure
    29. Tissue Microarray Market, By Technology
    30. Tissue Microarray Market, By Application
      1. Tissue Microarray
    31. Market, By End User
    32. Germany 78
    33. Tissue Microarray Market, By Procedure
      1. Tissue Microarray Market, By
      2. Technology
      3. Tissue
    34. Microarray Market, By Application
    35. Tissue Microarray Market, By End User
      1. Tissue Microarray Market,
      2. By Procedure
      3. Tissue
    36. France 81
    37. Microarray Market, By Technology
    38. Tissue Microarray Market, By Application
      1. Tissue Microarray Market,
      2. By End User
      3. 10.3.3
      4. UK 84
      5. Tissue
    39. Microarray Market, By Procedure
    40. Tissue Microarray Market, By Technology
      1. Tissue Microarray Market,
      2. By Application
      3. Tissue
    41. Microarray Market, By End User
    42. Italy 87
    43. Tissue Microarray Market, By Procedure
      1. Tissue Microarray
    44. Market, By Technology
    45. Tissue Microarray Market, By Application
    46. Tissue Microarray Market, By End User
      1. Tissue Microarray
    47. Spain 90
    48. Market, By Procedure
    49. Tissue Microarray Market, By Technology
    50. Tissue Microarray Market, By Application
      1. Tissue Microarray
    51. Market, By End User
    52. Rest Of Western Europe 93
    53. Tissue Microarray Market, By Procedure
      1. Tissue Microarray
    54. Market, By Technology
    55. Tissue Microarray Market, By Application
    56. Tissue Microarray Market, By End User
      1. 96
      2. Tissue
    57. Eastern Europe
    58. Microarray Market, By Procedure
    59. Tissue Microarray Market, By Technology
      1. Tissue Microarray Market,
      2. By Application
      3. Tissue
    60. Microarray Market, By End User
      1. Asia Pacific 100
    61. Tissue Microarray Market, By Procedure
      1. Tissue Microarray
    62. Market, By Technology
    63. Tissue Microarray Market, By Application
    64. Tissue Microarray Market, By End User
      1. Tissue Microarray
    65. Japan 104
    66. Market, By Procedure
    67. Tissue Microarray Market, By Technology
    68. Tissue Microarray Market, By Application
      1. Tissue Microarray
    69. Market, By End User
    70. China 107
    71. Tissue Microarray Market, By Procedure
      1. Tissue Microarray Market, By
      2. Technology
      3. Tissue
    72. Microarray Market, By Application
    73. Tissue Microarray Market, By End User
      1. Tissue Microarray Market,
      2. By Procedure
      3. Tissue
    74. India 110
    75. Microarray Market, By Technology
    76. Tissue Microarray Market, By Application
      1. Tissue Microarray Market,
      2. By End User
      3. 10.4.4
      4. Australia 113
      5. Tissue
    77. Microarray Market, By Procedure
    78. Tissue Microarray Market, By Technology
      1. Tissue Microarray Market,
      2. By Application
      3. Tissue
    79. Microarray Market, By End User
    80. Republic Of Korea 116
    81. Tissue Microarray Market, By Procedure
      1. Tissue Microarray
    82. Market, By Technology
    83. Tissue Microarray Market, By Application
    84. Tissue Microarray Market, By End User
      1. 119
      2. Tissue
    85. Rest Of Asia Pacific
    86. Microarray Market, By Procedure
    87. Tissue Microarray Market, By Technology
      1. Tissue Microarray Market,
      2. By Application
      3. Tissue
    88. Microarray Market, By End User
      1. Middle East & Africa 123
      2. Tissue Microarray Market, By
      3. Procedure
      4. Tissue
    89. Microarray Market, By Technology
    90. Tissue Microarray Market, By Application
      1. Tissue Microarray Market,
      2. By End User
      3. 10.5.1
      4. UAE 127
      5. Tissue
    91. Microarray Market, By Procedure
    92. Tissue Microarray Market, By Technology
      1. Tissue Microarray Market,
      2. By Application
      3. Tissue
    93. Microarray Market, By End User
    94. Saudi Arabia 130
    95. Tissue Microarray Market, By Procedure
      1. Tissue Microarray
    96. Market, By Technology
    97. Tissue Microarray Market, By Application
    98. Tissue Microarray Market, By End User
      1. Tissue Microarray
    99. Oman 133
    100. Market, By Procedure
    101. Tissue Microarray Market, By Technology
    102. Tissue Microarray Market, By Application
      1. Tissue Microarray
    103. Market, By End User
    104. Kuwait 136
    105. Tissue Microarray Market, By Procedure
      1. Tissue Microarray Market, By
      2. Technology
      3. Tissue
    106. Microarray Market, By Application
    107. Tissue Microarray Market, By End User
      1. Tissue Microarray Market,
      2. By Procedure
      3. Tissue
    108. Qatar 139
    109. Microarray Market, By Technology
    110. Tissue Microarray Market, By Application
      1. Tissue Microarray Market,
      2. By End User
      3. 10.5.6
      4. Rest Of Middle East & Africa 142
    111. Tissue Microarray Market, By Procedure
      1. Tissue Microarray
    112. Market, By Technology
    113. Tissue Microarray Market, By Application
    114. Tissue Microarray Market, By End User
    115. Competitive Landscape
      1. Introduction
      2. 146
      3. 11.2
      4. Company Share Analysis 146
    116. Company Profile
      1. Agilent Technologies 147
        1. Company Overview 147
        2. Product/Business Segment
        3. Key Development 149
        4. SWOT Analysis 150
      2. Overview 147
      3. 12.1.3
      4. Financial Overview 148
      5. Applied Microarrays 151
        1. Overview
        2. Financial Overview 151
        3. Key Development 151
        4. SWOT Analysis
        5. Financial Overview 153
        6. SWOT Analysis 154
      6. 151
      7. 12.2.2
      8. Product/Business Segment Overview 151
      9. 151
      10. 12.3
      11. Arrayit 153
      12. 12.3.1
      13. Overview 153
      14. 12.3.2
      15. Product/Business Segment Overview 153
      16. Asterand Bioscience
        1. Product/Business Segment Overview 155
        2. Financial Overview 155
        3. Key Developments
      17. 155
      18. 12.4.1
      19. Company Overview 155
      20. 155
      21. 12.4.5
      22. SWOT Analysis 156
      23. Horizon Discovery 157
        1. Overview 157
        2. Product/Business Segment Overview 157
        3. Financial
        4. SWOT Analysis 159
      24. Overview 157
      25. 12.5.4
      26. Key Development 158
      27. Illumina Inc. 160
        1. Company Overview 160
        2. Product/Business Segment
        3. Key Development 162
        4. SWOT Analysis 163
      28. Overview 160
      29. 12.6.3
      30. Financial Overview 161
      31. Protein Biotechnologies
        1. Product/Business Segment Overview 164
        2. Financial Overview 165
        3. Key Development
      32. Inc. 164
      33. 12.7.1
      34. Company Overview 164
      35. 165
      36. 12.7.5
      37. SWOT Analysis 165
      38. Pantomics Inc. 166
        1. Company Overview 166
        2. Product/Business Segment
        3. Key Development 166
        4. SWOT Analysis 167
      39. Overview 166
      40. 12.8.3
      41. Financial Overview 166
      42. Phalanx Biotech Group 168
        1. Overview
        2. Financial Overview 168
        3. Key Development 168
        4. SWOT Analysis
        5. Financial Overview 170
        6. Key Development 171
        7. SWOT Analysis
        8. Product/Business Segment Overview 173
        9. Financial Overview 173
        10. Key Development
      43. 168
      44. 12.9.2
      45. Product/Business Segment Overview 168
      46. 169
      47. 12.10
      48. Perkin Elmer 170
      49. 12.10.1
      50. Overview 170
      51. 12.10.2
      52. Product/Business Segment Overview 170
      53. 172
      54. 12.11
      55. QIAGEN 173
      56. 12.11.1
      57. Company Overview 173
      58. 174
      59. 12.11.5
      60. SWOT Analysis 175
      61. SeraCare 176
        1. Overview 176
        2. Product/Business Segment Overview 176
        3. Financial
        4. SWOT Analysis 177
      62. Overview 176
      63. 12.12.4
      64. Key Development 177
      65. Takara Bio Inc. 178
        1. Company Overview 178
        2. Product/Business
        3. Financial Overview 179
        4. Key Development 180
        5. SWOT Analysis 180
      66. Segment Overview 178
    117. MRFR Conclusion
      1. Key Findings
        1. Unmet Needs 182
      2. 182
      3. 13.1.1
      4. From CEO’s View Point 182
      5. Key Companies To Watch 182
      6.  
    118. List Of Tables
    119. MERGER AND ACQUISITION
      1. LANDSCAPE 35
      2. TABLE
    120. GLOBAL TISSUE MICROARRAY MARKET, BY PROCEDURE, 2020-2027 (USD MILLION) 37
    121. GLOBAL
    122. TISSUE MICROARRAY MARKET FOR IMMUNOHISTOCHEMISTRY, BY REGION, 2020-2027 (USD MILLION)
      1. 38
      2. TABLE
    123. GLOBAL TISSUE MICROARRAY MARKET FOR FLUORESCENT IN SITU HYBRIDIZATION, BY REGION,
    124. GLOBAL TISSUE MICROARRAY MARKET FOR FROZEN TISSUE ARRAY, BY
      1. REGION, 2020-2027 (USD MILLION) 40
    125. GLOBAL TISSUE MICROARRAY MARKET, BY TECHNOLOGY,
    126. GLOBAL TISSUE MICROARRAY MARKET FOR DNA MICROARRAY, BY REGION,
    127. GLOBAL TISSUE MICROARRAY MARKET FOR POLYMERASE CHAIN REACTION
      1. (PCR), BY REGION, 2020-2027 (USD MILLION) 44
    128. GLOBAL TISSUE MICROARRAY MARKET FOR NEXT-GENERATION
      1. SEQUENCING, BY REGION, 2020-2027 (USD MILLION) 45
    129. GLOBAL TISSUE MICROARRAY MARKET FOR NORTHERN
      1. BLOTTING, BY REGION, 2020-2027 (USD MILLION) 46
    130. GLOBAL TISSUE MICROARRAY MARKET FOR WESTERN
      1. BLOTTING, BY REGION, 2020-2027 (USD MILLION) 47

      2. Tissue Microarray Market Segmentation

        Market Segmentation Overview

        • Detailed segmentation data will be available in the full report
        • Comprehensive analysis by multiple parameters
        • Regional and country-level breakdowns
        • Market size forecasts by segment
    Infographic

    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Get Free Sample

    Related Reports

    Regional Reports
    Country Reports

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne

    Founder
    Case Study
    Chemicals and Materials
    Global Magnesium Sulfate Market – Forecast till 2027